On 31 October 2025, Shanghai Haohai Biological Technology Co., Ltd. (06826.HK, 688366.SH) disclosed its Next Day Disclosure Return. The number of H shares remained unchanged at 38,529,240 as of 31 October 2025. Several batches of repurchased H shares from September and October 2025 have not yet been canceled, including a final batch of 45,500 shares repurchased on 31 October 2025.

As of the same date, the A shares stood at 190,203,760 with an additional 3,848,095 shares held in treasury for a total of 194,051,855. According to the repurchase report, the 45,500 H shares bought on 31 October 2025 were acquired via on-exchange transactions, with the highest price at HKD 27.50 and the lowest at HKD 27.36, totaling HKD 1,250,288.

Furthermore, the total number of H shares repurchased under the current mandate reached 277,200, equivalent to 0.7082% of the company’s issued shares as of the resolution date. The mandate authorizes repurchases of up to 3,914,184 H shares and stipulates a moratorium on new share issues through 30 November 2025, following the recent repurchase activity.